IL75490A0 - Controlled release pharmaceutical compositions containing solid dispersions of active agent - Google Patents

Controlled release pharmaceutical compositions containing solid dispersions of active agent

Info

Publication number
IL75490A0
IL75490A0 IL75490A IL7549085A IL75490A0 IL 75490 A0 IL75490 A0 IL 75490A0 IL 75490 A IL75490 A IL 75490A IL 7549085 A IL7549085 A IL 7549085A IL 75490 A0 IL75490 A0 IL 75490A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
active agent
controlled release
compositions containing
containing solid
Prior art date
Application number
IL75490A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL75490A0 publication Critical patent/IL75490A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL75490A 1984-06-14 1985-06-12 Controlled release pharmaceutical compositions containing solid dispersions of active agent IL75490A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (1)

Publication Number Publication Date
IL75490A0 true IL75490A0 (en) 1985-10-31

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75490A IL75490A0 (en) 1984-06-14 1985-06-12 Controlled release pharmaceutical compositions containing solid dispersions of active agent

Country Status (21)

Country Link
AT (1) AT391806B (nl)
AU (2) AU587190B2 (nl)
BE (1) BE902626A (nl)
CA (1) CA1264441A (nl)
CY (1) CY1635A (nl)
DE (1) DE3520184C2 (nl)
DK (1) DK167649B1 (nl)
ES (1) ES8702141A1 (nl)
FR (1) FR2565822B1 (nl)
GB (3) GB2160100B (nl)
GR (1) GR851430B (nl)
HK (1) HK25192A (nl)
HU (1) HU198844B (nl)
IE (1) IE58834B1 (nl)
IL (1) IL75490A0 (nl)
IT (1) IT1200080B (nl)
LU (1) LU85946A1 (nl)
NL (1) NL194389C (nl)
NZ (1) NZ212390A (nl)
PT (1) PT80635B (nl)
SE (1) SE504583C2 (nl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
AU695734B2 (en) 1996-07-08 1998-08-20 Penwest Pharmaceuticals Co. Sustained release matrix for high-dose insoluble drugs
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
WO2000076480A2 (en) * 1999-06-11 2000-12-21 Eli Lilly And Company Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
EP1205190B1 (en) * 1999-08-04 2006-05-03 Astellas Pharma Inc. Stable medicinal compositions for oral use using ferric oxides
WO2001022940A1 (en) 1999-09-30 2001-04-05 Edward Mendell Co., Inc. Sustained release matrix systems for highly soluble drugs
JP2004518709A (ja) * 2001-02-13 2004-06-24 アストラゼネカ・アクチエボラーグ 新規放出修飾製剤
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (de) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Herstellung von Dosierungsformen mit einer festen Dispersion eines mikrokristallinen Wirkstoffs
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
WO2008070118A1 (en) 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
MX2011001864A (es) 2008-08-20 2011-06-20 Univ Texas Extrusion de fusion en caliente de multiples particulas de liberacion modificada.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (de) * 1967-11-17 1971-03-25 Beiersdorf Ag Verfahren zur Herstellung von Arzneimitteln mit verzoegerter Wirkstoffabgabe in Form von Kapseln
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
DE2549740A1 (de) * 1975-11-17 1977-05-18 Sandoz Ag Neue galenische formen und verfahren zu deren herstellung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DK149855C (da) * 1977-06-20 1987-04-21 Sandoz Ag Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DK154607C (da) * 1978-12-21 1989-06-05 Sandoz Ag Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung

Also Published As

Publication number Publication date
HU198844B (en) 1989-12-28
PT80635A (en) 1985-07-01
DK264785A (da) 1985-12-15
SE504583C2 (sv) 1997-03-10
AU4454389A (en) 1990-03-22
HUT40918A (en) 1987-03-30
HK25192A (en) 1992-04-10
IT8548210A0 (it) 1985-06-13
GB2160100A (en) 1985-12-18
FR2565822A1 (fr) 1985-12-20
DK264785D0 (da) 1985-06-12
GB2196851B (en) 1989-06-07
FR2565822B1 (fr) 1989-02-17
IT1200080B (it) 1989-01-05
PT80635B (pt) 1987-10-20
SE8502950D0 (sv) 1985-06-13
GR851430B (nl) 1985-11-25
DK167649B1 (da) 1993-12-06
NL194389B (nl) 2001-11-01
GB2196852A (en) 1988-05-11
IE851460L (en) 1985-12-14
AU4348685A (en) 1985-12-19
DE3520184A1 (de) 1985-12-19
NL8501578A (nl) 1986-01-02
SE8502950L (sv) 1985-12-15
ES8702141A1 (es) 1987-01-01
NL194389C (nl) 2002-03-04
AT391806B (de) 1990-12-10
DE3520184C2 (de) 1997-03-13
GB2196851A (en) 1988-05-11
LU85946A1 (fr) 1986-01-24
GB2160100B (en) 1989-06-01
GB2196852B (en) 1989-05-17
ES544075A0 (es) 1987-01-01
IE58834B1 (en) 1993-11-17
GB8514855D0 (en) 1985-07-17
ATA174885A (de) 1990-06-15
GB8727055D0 (en) 1987-12-23
AU587190B2 (en) 1989-08-10
CY1635A (en) 1992-11-06
CA1264441A (en) 1990-01-16
GB8727056D0 (en) 1987-12-23
BE902626A (fr) 1985-12-10
NZ212390A (en) 1992-02-25

Similar Documents

Publication Publication Date Title
IL75490A0 (en) Controlled release pharmaceutical compositions containing solid dispersions of active agent
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
EP0467488A3 (en) Composition for the controlled discharge of an active ingredient
GB8502974D0 (en) Sustained release of active substance
PT81746A (en) Process for the preparation of peptide-aldehydes and of pharmaceutical compositions containing them
GB2143734B (en) Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
GB2120937B (en) Implant for sustained release of pharmaceutical agents
DE3571924D1 (en) Dosage units for controlled release of active material
PT81502A (en) Process for the preparation of cholecalciferol derivatives and of pharmaceutical compositions containing the same
PT80794A (en) Process for the preparation of novel isoindolinyl-alkyl-piperazines and of pharmaceutical compositions containing the same
PT79858A (en) Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith
EP0277740A3 (en) Aqueous film-forming compositions for controlling the release of active agents and process of making same
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
HUT39450A (en) Process for producing imidazobicyclic compounds and pharmaceutical compositions containing them as active agents
PT81083A (en) Process for the preparation of substituted 7-oxomitosanes and of pharmaceutical compositions containing the same
PT80315B (en) Process for the preparation of imidazole derivatives and of pharmaceutical compositions containing the same
GB2161382B (en) Pharmaceutical and cosmetic compositions containing 1 8-dihydroxy-10-phenyl-9-anthrone and process for the preparation of this compound
IL64827A0 (en) Fungicidal compositions containing certain amino acid derivatives and the preparation of these derivatives
HUT35924A (en) Fungicide composition or regulated release of active agents
PT75281A (en) Process for the preparation of biologically active hydrazonocephem derivatives and of pharmaceutical compositions containing the same
PT83456A (en) Process for the preparation of pharmaceutical compositions with controlled release of active substance
PT79990A (en) Process for the preparation of diazepine-indoles and of pharmaceutical compositions therewith
IL74459A (en) Controlled release pharmaceutical compositions containing bromocriptine
HUT37785A (en) Process for producing 3-alkoxy-2-pyrrolidino-n-pyrimidinyl-or -n-pyrazinyl-propyl-amines and pharmaceutical compositions containing them as active agents
HU906363D0 (en) Herbicide compositions containing n-amino-triazole-derivatives and process for the preparation of the active agents

Legal Events

Date Code Title Description
RH Patent void